Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 변지연 | * |
dc.date.accessioned | 2021-12-01T16:30:56Z | - |
dc.date.available | 2021-12-01T16:30:56Z | - |
dc.date.issued | 2021 | * |
dc.identifier.issn | 1013-9087 | * |
dc.identifier.issn | 2005-3894 | * |
dc.identifier.other | OAK-30557 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/259605 | - |
dc.description.abstract | Background: In 2015, the Korean Atopic Dermatitis Association (KADA) working group published consensus guidelines for treating atopic dermatitis (AD). Objective: We aimed to provide updated consensus recommendations for systemic treatment of AD in South Korea based on recent evidence and experience. Methods: We compiled a database of references from relevant systematic reviews and guidelines on the systemic management of AD. Evidence for each statement was graded and classified based on thestrength of the recommendation. Forty-two council members from the KADA participated in three rounds of voting to establish a consensus on expert recom-mendations. Results: We do not recommend long-term treatment with systemic steroids forpatients with moderate-to-severe AD due to the risk of adverse effects. We recommend treatment with cyclosporine or dupilumab and selective treatment with methotrexate or azathioprine for patients with moderate-to-severe AD. We suggest treatment with antihistamines as an option for alleviating clinical symptoms of AD. We recommend selective treatment with narrowband ultraviolet B for patients with chronic moderate-to-severe AD. We do not rec-ommend treatment with oral antibiotics for patients with moderate-to-severe AD but who have no signs of infection. We did not reach a consensus on recommendations for treat-ment with allergen-specific immunotherapy, probiotics, evening primrose oil, orvitamin D for patients with moderate-to-severe AD. We also recommend educational interventions and counselling for patients with AD and caregivers to improve the treatment success rate. Conclusion: We look forward to implementing a new and updated consensus of systemic therapy in controlling patients with moderate-to-severe AD. | * |
dc.language | English | * |
dc.publisher | KOREAN DERMATOLOGICAL ASSOC | * |
dc.subject | Atopic dermatitis | * |
dc.subject | Consensus | * |
dc.subject | Republic of Korea | * |
dc.subject | Systemic treatment | * |
dc.subject | Therapeu-tics | * |
dc.title | Consensus Update for Systemic Treatment of Atopic Dermatitis | * |
dc.type | Article | * |
dc.relation.issue | 6 | * |
dc.relation.volume | 33 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.index | KCI | * |
dc.relation.startpage | 497 | * |
dc.relation.lastpage | 514 | * |
dc.relation.journaltitle | ANNALS OF DERMATOLOGY | * |
dc.identifier.doi | 10.5021/ad.2021.33.6.497 | * |
dc.identifier.wosid | WOS:000718138800002 | * |
dc.identifier.scopusid | 2-s2.0-85119609554 | * |
dc.author.google | Lee, Ji Hyun | * |
dc.author.google | Kim, Jung Eun | * |
dc.author.google | Park, Gyeong-Hun | * |
dc.author.google | Bae, Jung Min | * |
dc.author.google | Byun, Ji Yeon | * |
dc.author.google | Shin, Min Kyung | * |
dc.author.google | Han, Tae Young | * |
dc.author.google | Hong, Seung Phil | * |
dc.author.google | Jang, Yong Hyun | * |
dc.author.google | Kim, Hye One | * |
dc.author.google | Na, Chan Ho | * |
dc.author.google | Lew, Bark-Lynn | * |
dc.author.google | Ahn, JiYoung | * |
dc.author.google | Park, Chang Ook | * |
dc.author.google | Seo, Young-Joon | * |
dc.author.google | Lee, Yang Won | * |
dc.author.google | Son, Sang Wook | * |
dc.author.google | Choi, Eung Ho | * |
dc.author.google | Park, Young Lip | * |
dc.author.google | Roh, Joo Young | * |
dc.contributor.scopusid | 변지연(15724462400) | * |
dc.date.modifydate | 20240222131101 | * |